Search

You searched for "pharmaceuticals"

128 results found

Théa Pharmaceuticals are excited to be attending RCOphth Congress 2023 with two innovative new products.

22 May 2023 | Research & Development, Awards, Conferences & Anniversaries
This year Théa will also have two stands – one right by the registration desk which will be focused on product sampling and a larger stand inside the main exhibition hall which will showcase the wider product range.

Pharmaceuticals

Med Sales Academy: Introduction to Medical Device Sales

25 September 2024
We are serious about providing you with more than a course, we offer you a framework for success and a support network as you embark on a career in medical sales. Our Online Introduction to Medical Sales Course is aimed at Graduates, Healthcare Professionals and Professionals, who are keen to pursue a career in the Medical Device or Pharmaceutical Industries.

Corporate M&A pace gathers momentum

1 October 2019 | | AMD, Cataract and Refractive, Cornea / External Eye Disease, Emergency Ophthalmology, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | Cataract and Refractive, Cornea / External Eye Disease, Genetics, Glaucoma, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...

Entries open for SOC e-poster competition

15 January 2021
The Scottish Ophthalmological Club meeting will take place on 24 February.

Moorfields International Corneal & Cataract Symposium 2024

12 October 2024
Mr Alexander Ionides & Mr Mark Wilkins, supported by Théa Pharmaceuticals, NuVison Biotherapies, Altomed Ltd. and Daybreak Medical, are pleased to invite you to register your place for the 2024 Moorfields International Corneal & Cataract Symposium! The programme is under construction and will include 14 talks on current Cornea & Cataract topics from Moorfields, UK and international keynote speakers. Confirmed keynote speakers include Dr Soosan Jacob from Dr Agarwal’s Group of Eye Hospitals, Chennai, India, Prof Adnan Tufail and Prof Paul Foster from Moorfields Eye Hospital NHS Foundation Trust. Thea are pleased to be the gold sponsors of this event along with Altomed, NuVision and Daybreak - silver sponsors.

SOC welcomes registrations and poster submissions for September meeting

27 July 2021
The theme of the Scottish Ophthalmological Club spring meeting on 23 September is ‘Post COVID – The Best of Times and The Worst of Times', featuring eminent speakers on a range of topics.

A Scottish first: SOC goes virtual

28 July 2020
The first virtual Scottish Ophthalmology Club (SOC) meeting will be held on Wednesday 30 September 2020.

Survey reveals poor public awareness of dry eye disease

17 May 2021
A new survey has revealed how few people are aware of Dry Eye Disease, a debilitating and painful eye condition which affects one in four people in the UK.

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

5 June 2023 |
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Congratulations to the SOC poster prize winners!

24 September 2021
The Scottish Ophthalmological Club (SOC) recently hosted another excellent webinar on the theme ‘Post COVID – The Best of Times and The Worst of Times'.